Liver Disease

Liver Disease Tests help identify liver injury, measure how well the liver works, and look for common causes such as viral hepatitisfatty liver (metabolic)alcohol-related diseaseautoimmune conditions, and genetic disorders. Because early liver disease is often silent, proactive testing can catch problems sooner and guide next steps.

A smart starting point is a hepatic function panel (AST, ALT, alkaline phosphatase, GGT, total/direct bilirubin, albumin, total protein) plus PT/INRplatelets/CBC, and basic kidney/sodium for safety. Add hepatitis B/C panelsautoimmune markers (ANA, ASMA, AMA), iron studiesceruloplasmin (Wilson disease), and alpha-1 antitrypsin when patterns or risks suggest them. Noninvasive fibrosis scores calculated from routine labs (FIB-4, APRI; ELF where available) help estimate scarring risk. Labs support screeningdiagnosisstaging, and monitoring, but do not replace a clinician’s exam, ultrasound/elastography, or endoscopy when needed.

Signs, Symptoms & Related Situations

  • Often silent early: abnormal labs on a routine panel

  • Skin/eyes & digestion: jaundice, dark urine, pale stools, itching, poor appetite, nausea

  • Abdomen & fluid: bloating or ascites, rapid weight change, leg swelling

  • Bleeding/energy: easy bruising/bleeding, fatigue, weakness

  • Thinking changes: trouble concentrating, sleep reversal, confusion (possible encephalopathy)

  • Risks & exposures: viral hepatitis, alcohol, metabolic syndrome (central weight, diabetes, high triglycerides), family history of iron/copper/A1AT disorders, autoimmune disease, certain medications/supplements

  • Urgent care now: vomiting blood or black stools, severe abdominal swelling with pain/fever, confusion, chest pain, or trouble breathing

All symptoms and risks should be reviewed by a qualified clinician.

Why These Tests Matter

What testing can do

  • Reveal injury patterns (hepatocellular vs. cholestatic) and synthetic function (albumin, INR)

  • Help identify causes (hepatitis viruses, autoimmune markers, iron/copper/A1AT abnormalities)

  • Provide risk clues for scarring using platelets and calculated fibrosis scores (FIB-4/APRI/ELF)

  • Track trends to guide follow-up timing and imaging

What testing cannot do

  • Confirm cirrhosis or cancer on labs alone—imaging/elastography (and sometimes biopsy) may be needed

  • Replace a clinician’s exam, medication/alcohol review, or nutrition counseling

  • Provide treatment or dosing advice—use results to plan with your clinician

What These Tests Measure (at a glance)

  • AST & ALT: enzymes of liver cell injury; ALT is more liver-specific.

  • Alkaline Phosphatase (ALP) & GGT: markers of cholestasis; GGT helps confirm a liver source when ALP is high.

  • Bilirubin (total/direct): high levels cause jaundice; patterns suggest blockage vs. overproduction.

  • Albumin & Total Protein (± A/G ratio): reflect synthetic function and nutrition/inflammation context.

  • PT/INR: clotting proteins made by the liver; prolonged INR indicates reduced synthesis.

  • Platelets & CBC: low platelets can point to portal hypertension; CBC adds anemia/infection context.

  • Basic metabolic panel (sodium, creatinine/eGFR): overall safety; components feed risk scores.

  • Hepatitis testing: HBsAg, anti-HBs, anti-HBcHCV Ab with reflex RNAHAV IgM/totalHDV/HEV in select cases.

  • Autoimmune markers: ANA, ASMA, AMAIgG/IgM—support autoimmune hepatitis or primary biliary cholangitis patterns.

  • Iron & genetics: Ferritin, iron/TIBC, transferrin saturation (hemochromatosis risk); HFE testing per clinician.

  • Wilson & A1AT: Ceruloplasmin (± copper studies) for Wilson disease; alpha-1 antitrypsin level/phenotype for A1AT deficiency.

  • Metabolic risk: A1clipid panel for fatty liver risk.

  • Fibrosis estimation: FIB-4, APRI (from age, AST, ALT, platelets), ELF where available.

  • HCC marker (context): AFP may support surveillance programs alongside ultrasound.

Quick Build Guide

Clinical goal Start with Add if needed
Abnormal liver enzymes Liver panel • PT/INR • Platelets/CBC • BMP (Na, creatinine) HBV/HCV panels • Ferritin/Iron/TIBC • A1c/Lipids • ANA/ASMA/AMA
Fatty liver risk (metabolic) AST/ALT • GGT • Platelets • Albumin • A1c • Lipids Calculate FIB-4/APRI; rule out HBV/HCV
Cholestatic pattern (ALP/GGT high) Liver panel • Direct bilirubin AMA • IgM (PBC context); clinician-directed imaging
Possible alcohol-related pattern AST/ALT • GGT • Platelets • INR • Albumin Hepatitis panels • Ferritin; discuss alcohol history with clinician
Unclear cause Liver panel • PT/INR • CBC HBV/HCV • Ferritin/Iron/TIBC • Ceruloplasmin • A1AT • ANA/ASMA/AMA
Monitoring known liver disease Bilirubin • INR • Creatinine • Sodium • Albumin • Platelets AFP for HCC surveillance; trend MELD-type labs

How the Testing Process Works

  1. Choose your starting set: most users begin with a hepatic function panelPT/INRCBC/platelets, and BMP.

  2. Add cause-finding labs: based on history and patterns, include hepatitis panelsautoimmune markers, and iron/copper/A1AT studies.

  3. Provide a blood sample: no routine fasting (fast only for lipids). List all medicines and supplements on your order.

  4. Get results securely: most values post within a few days.

  5. Plan next steps: your clinician may recommend ultrasound/FibroScan, MRI, or endoscopy. Recheck at set intervals to monitor trends.

Interpreting Results (General Guidance)

  • AST/ALT predominant elevation: hepatocellular injury (e.g., viral hepatitis, metabolic/fatty liver, alcohol, medication).

  • ALP ± GGT predominant elevation: cholestasis or bile-duct disease.

  • Rising bilirubin, high INR, low albumin: reduced synthetic function—closer follow-up needed.

  • Low platelets: may reflect portal hypertension; correlate with imaging and exam.

  • High ferritin with high transferrin saturation: consider iron overload; discuss HFE testing.

  • Low ceruloplasmin (younger patients): consider Wilson disease with clinician guidance.

  • High FIB-4/APRI: suggests advanced fibrosis; confirm with elastography.
    Always interpret results with a qualified healthcare professional; patterns and trends matter more than any single value.

Choosing Panels vs. Individual Tests

  • Foundational liver set: Liver panel • PT/INR • CBC/Platelets • BMP (Na, creatinine)

  • Cause-finding add-ons: HBV/HCV panels • ANA/ASMA/AMA • Ferritin/Iron/TIBC • Ceruloplasmin • Alpha-1 Antitrypsin • A1c/Lipids

  • Fibrosis staging: calculate FIB-4/APRI (± ELF where available); imaging remains key

  • Monitoring: repeat bilirubin, INR, creatinine, sodium, albumin, platelets; add AFP per surveillance plans

FAQs

Do I need to fast for liver tests?
No. Fast only if your order includes lipids.

Can medications or supplements change my results?
Yes. Many drugs and some supplements affect liver enzymes. List everything you take on the order.

Are normal liver tests a clean bill of health?
Not always. Compensated liver disease can have near-normal labs; risk-based monitoring still matters.

What’s the difference between LFTs and “liver function”?
“LFTs” include injury markers (AST/ALT, ALP/GGT) and function markers (albumin, INR). Both are useful.

What is FIB-4?
noninvasive fibrosis score calculated from age, AST, ALT, and platelets; high values suggest more scarring.

Do labs alone diagnose cirrhosis?
No. Labs support the diagnosis; ultrasound/elastography (and sometimes biopsy) confirm stage.

How often should I recheck labs?
Timing depends on results and risk. Many people recheck every 3–12 months—follow your clinician’s plan.

Related Categories & Key Tests

  • Liver & Gallbladder Tests Hub

  • Hepatic Function Tests • Hepatitis Screening Tests • Cirrhosis Tests • Fatty Liver (Metabolic) • Autoimmune Liver Disease • Hemochromatosis • Wilson’s Disease

  • Key Tests : AST • ALT • Alkaline Phosphatase • GGT • Total/Direct Bilirubin • Albumin • Total Protein • PT/INR • Platelets/CBC • Sodium • Creatinine/eGFR • HBsAg • Anti-HBs • Anti-HBc • HCV Ab ± RNA • ANA • ASMA • AMA • Ferritin • Iron/TIBC • Transferrin Saturation • Ceruloplasmin • Alpha-1 Antitrypsin Level/Phenotype • A1c • Lipid Panel • FIB-4/APRI (calculated) • ELF (where available) • AFP

References

  • American Association for the Study of Liver Diseases (AASLD) — Guidance on evaluation of abnormal liver chemistries and chronic liver diseases.
  • AASLD — Guidance on MASLD/NAFLD, autoimmune liver disease, and cholestatic disease.
  • European Association for the Study of the Liver (EASL) — Clinical practice guidelines on liver disease assessment and fibrosis.
  • World Health Organization — Hepatitis B and C testing guidelines.
  • U.S. Preventive Services Task Force — Screening for Hepatitis B and C.
  • Clinical reviews on noninvasive fibrosis scores (FIB-4, APRI, ELF) and laboratory monitoring in liver disease.

Available Tests & Panels

Your Liver Disease Tests menu is pre-populated in the Ulta Lab Tests system. Use filters to build the right package—hepatic function panelPT/INRCBC/plateletsBMP, plus hepatitis panelsautoimmune markersiron/copper/A1AT studies, and fibrosis scoring support. Review results with your clinician to plan imaging, follow-up timing, and ongoing monitoring.

  • Page
  • 2
  • of
  • 5
  • Total Rows
  • 113
Name Matches
Most Popular

The CA 19-9 Test measures levels of carbohydrate antigen 19-9 in blood, a tumor marker often elevated in pancreatic cancer and sometimes in bile duct, colorectal, or liver cancers. While not used alone for diagnosis, it helps monitor treatment, track disease progression, and detect recurrence. Elevated CA 19-9 may also occur in noncancerous conditions. Doctors use this test to support cancer management and guide therapy decisions.

Blood
Blood Draw
Also Known As: CA 19-9 Tumor Marker, Cancer Antigen 19-9 Test

The Cardio IQ™ Fibrinogen Antigen Test evaluates fibrinogen concentration, a key protein that influences clotting and cardiovascular disease risk. It provides insight into vascular inflammation, atherosclerosis, and thrombotic events. This test helps identify factors that contribute to stroke, coronary artery disease, and systemic vascular complications, offering valuable information for assessing overall cardiovascular health.

Blood
Blood Draw
Also Known As: Fibrinogen Antigen Nephelometry Test

The Cardio IQ™ Triglycerides Test measures triglyceride levels in the blood, an important marker of lipid metabolism and cardiovascular health. Elevated triglycerides are linked to increased risk of heart disease, pancreatitis, and metabolic syndrome. Physicians use this test to assess risk factors, monitor therapy response, and guide lifestyle or treatment decisions, often as part of a broader lipid or heart health evaluation.

Blood
Blood Draw

The Cardio IQ Vitamin D test, also known as a 25-hydroxy vitamin D test, measures the levels of total vitamin D in the blood, including both vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). It provides information about an individual's overall vitamin D status.

Blood
Blood Draw
Also Known As: Ergocalciferol Test, Vitamin D2 Test, Cholecalciferol Test, Vitamin D3 Test, Calcidiol Test, 25-hydroxyvitamin D Test, Calcifidiol Test, 25-hydroxy-vitamin D Test

The Catecholamines Fractionated Plasma Test measures plasma levels of dopamine, epinephrine, and norepinephrine, hormones that regulate stress response, blood pressure, and heart rate. Elevated levels may indicate pheochromocytoma, paraganglioma, or other adrenal and nervous system disorders. Doctors use this test to investigate symptoms like hypertension, headaches, sweating, or palpitations, and to monitor treatment of adrenal tumors.

Blood
Blood Draw

Most Popular

The CEA Test measures carcinoembryonic antigen levels in blood, a protein that may be elevated in certain cancers, especially colorectal, pancreatic, lung, breast, or ovarian cancer. It is not used alone for diagnosis but helps monitor cancer treatment, detect recurrence, and track disease progression. Elevated CEA can also occur in noncancerous conditions. Doctors use this test to support therapy decisions and provide insight into cancer management.

Blood
Blood Draw
Also Known As: Carcinoembryonic Antigen Test

The Ceruloplasmin Test measures levels of ceruloplasmin, a copper-carrying protein made in the liver, to evaluate copper metabolism and related disorders. Low levels may indicate Wilson’s disease, Menkes disease, or severe liver disease, while high levels may suggest inflammation or pregnancy. Doctors order this test for patients with liver problems, neurological symptoms, or abnormal copper levels. Results help diagnose metabolic disorders and guide treatment.

Blood
Blood Draw
Also Known As: Copper Oxide Test, Wilson’s Disease Test

The Cholesterol Total Test measures the overall amount of cholesterol in blood, combining LDL and HDL, to evaluate cardiovascular health. High cholesterol is a major risk factor for heart disease, atherosclerosis, and stroke, while low levels may also affect health. Doctors use this test for routine screening, monitoring treatment, and assessing heart risk. Results provide key insight into lipid balance, helping guide lifestyle changes and therapy decisions.

Blood
Blood Draw
Also Known As: Blood Cholesterol Test

The Complement Component C3c and C4c Test measures levels of two key proteins in the complement system, which supports immune defense and inflammation control. Abnormal results may indicate autoimmune disease, lupus, rheumatoid arthritis, or certain infections. Doctors use this test to investigate unexplained inflammation, monitor disease activity, and guide treatment decisions in patients with suspected immune or inflammatory disorders.

Also Known As: C3 and C4 Test, Complement C3 and C4 Test, Complement Test

The Complement Component C4c Test measures blood levels of C4c, a protein in the complement system that supports immune defense and inflammation control. Abnormal levels may indicate autoimmune disorders such as lupus, rheumatoid arthritis, or immune complex disease, as well as certain kidney conditions. Doctors use this test to evaluate complement activation, confirm diagnosis, and monitor treatment response in patients with suspected immune-related diseases.

Blood
Blood Draw
Also Known As: C4 Test, Complement C4 Test, Complement Test

The Complement Total CH50 Test measures overall activity of the complement system, a key part of the immune response that helps fight infections and regulate inflammation. Abnormal results may indicate autoimmune diseases such as lupus, complement deficiencies, or immune complex disorders. Doctors use this blood test to evaluate immune function, investigate recurrent infections, and monitor treatment in patients with suspected immune or autoimmune conditions.

Blood
Blood Draw
Also Known As: Total Complement Test, Total Complement Activity Test

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Blood
Blood Draw
Also Known As: CBC Test, CBC with Differential and Platelets Test, CBC w/Diff and Platelets Test, Full Blood Count Test, Complete Blood Count Test

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Blood
Blood Draw
Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Copper Micronutrient Plasma Test measures copper levels in the blood to evaluate nutritional status and detect deficiencies or excess. Copper is essential for red blood cell formation, connective tissue health, energy production, and nervous and immune system function. This test helps identify imbalances from poor diet, malabsorption, or toxicity, supporting diagnosis and management of overall health.

Patient must be 18 years of age or older.
Blood
Blood Draw

Most Popular

The Copper Test measures copper levels in blood to evaluate nutritional status, liver function, and metabolic health. Abnormal levels may indicate Wilson’s disease, Menkes disease, liver disorders, or malnutrition. Both deficiency and excess copper can affect nervous system, immune function, and energy metabolism. Doctors use this test to investigate unexplained symptoms, monitor treatment, or assess copper-related disorders, providing key insight into overall health.

Blood
Blood Draw
Also Known As: Cu Test, Copper Serum Test, Copper Plasma Test

The Copper Blood Test measures copper levels in the blood to evaluate nutritional status, metabolic function, and potential toxicity. Abnormal levels may be linked to Wilson’s disease, Menkes disease, liver dysfunction, or excessive exposure. This test helps assess unexplained fatigue, neurological symptoms, or metabolic imbalance, supporting evaluation of trace element health and copper-related disorders.

Blood
Blood Draw
Also Known As: Cu Blood Test, Cu Test, Blood Copper Test, Hepatic Copper Test, Copper Free Test

The DCP Test detects des-gamma-carboxy prothrombin, an abnormal form of prothrombin linked to hepatocellular carcinoma and other liver disorders. Elevated levels may reflect tumor activity, chronic liver disease, or cirrhosis. This test provides valuable information for assessing liver function, monitoring cancer progression, and evaluating systemic health in patients with hepatic disease.

Blood
Blood Draw
Also Known As: Des-Gamma-Carboxy-Prothrombin Test

The Delta Aminolevulinic Acid Random Urine Test evaluates ALA excretion to screen for porphyrias and disorders of heme metabolism. Increases in urinary ALA can signal acute hepatic porphyria, lead toxicity, or disruptions in enzyme activity. This test is valuable in assessing recurrent abdominal pain, neuropathy, or unexplained neuropsychiatric symptoms, providing clinicians with insight into metabolic pathways and aiding differentiation from other systemic conditions.

Urine
Urine Collection

Most Popular

The Ferritin Test measures ferritin, a protein that stores iron in the body, to evaluate iron levels and detect deficiency or overload. It helps diagnose anemia, iron deficiency, hemochromatosis, and chronic disease-related inflammation. Doctors often order the ferritin test to investigate fatigue, weakness, or unexplained symptoms. It is also used to monitor iron supplementation, treatment effectiveness, and overall iron metabolism health.

Blood
Blood Draw
Also Known As: Iron Storage Test

The Ferritin, Iron and Total Iron Binding Capacity Panel measures ferritin, iron, TIBC, and % iron saturation to assess how well your body stores and transports iron. This panel helps detect iron deficiency, anemia, or iron overload, providing insight into energy levels, oxygen transport, and overall metabolic health.

Blood
Blood Draw

The Fibrinogen Antigen Test measures the amount of fibrinogen, a protein essential for blood clot formation and wound healing. Low levels may reflect bleeding disorders, liver disease, or fibrinolysis, while elevated levels are linked to inflammation and cardiovascular risk. This test provides insight into coagulation status, thrombotic risk, and systemic inflammation, supporting evaluation of clotting function and overall vascular health.

Blood
Blood Draw
Also Known As: Fibrinogen Antigen Nephelometry Test

The Galectin-3 Test measures levels of galectin-3, a biomarker linked to heart failure, cardiac fibrosis, and inflammation. Elevated results may indicate worsening heart disease, increased risk of hospitalization, or progression of chronic conditions. Doctors use this blood test to assess heart health, guide treatment decisions, and monitor patients with heart failure, offering valuable insight into long-term cardiovascular risk and management.

Blood
Blood Draw

Most Popular

The GGT Test measures gamma-glutamyl transferase, an enzyme found in the liver and bile ducts, to evaluate liver health. Elevated GGT may indicate liver disease, bile duct obstruction, alcohol use, or medication side effects. Doctors order this test to investigate symptoms like fatigue, jaundice, dark urine, or abdominal pain and to monitor liver damage. It is often performed with other liver tests to provide a complete picture of liver and bile duct function.

Blood
Blood Draw
Also Known As: Gamma Glutamyl Transferase Test, Gamma Glutamyl TransPeptidase Test, GGTP Test, GTP Test

Most Popular

The Glucose Test measures blood sugar levels to evaluate energy metabolism and screen for diabetes or prediabetes. Abnormal glucose may indicate hyperglycemia, hypoglycemia, or metabolic disorders. Doctors use this test during routine exams, to investigate symptoms like fatigue, excessive thirst, or frequent urination, and to monitor treatment for diabetes. It provides essential insight into how the body regulates blood sugar and overall metabolic health.

Blood
Blood Draw
Also Known As: Fasting Glucose Test, Fasting Blood Sugar Test

The Hepatic Function Panel Test measures liver enzymes, proteins, and bilirubin to assess liver health and function. It includes ALT, AST, ALP, albumin, total protein, and bilirubin levels. Abnormal results may indicate hepatitis, cirrhosis, fatty liver, or bile duct problems. Doctors use this test to investigate jaundice, nausea, abdominal pain, or fatigue and to monitor liver disease, alcohol use, or medication side effects affecting liver function.

Blood
Blood Draw
Also Known As: Liver Function Panel Test, LFT

On the right side of the body, located on the upper side of the abdomen, is the liver. Approximately the size of a football, the liver weighs about 2 to 3 pounds and works to do a variety of functions in the body, including the following:

  • Metabolize and detox harmful substances in the body
  • Convert nutrients that are derived from food into the vital blood components
  • Regulate the body’s ability to clot blood
  • Produce proteins and enzymes
  • Maintain the hormonal balance
  • Store specific vitamins
  • Contribute to the factors that aid in fighting the immune system
  • Remove toxic bacteria from the blood
  • Create bile that is vital for digestion

Bile is a green-yellow fluid that is comprised of bile acids or salts that are created via waste products like bilirubin that are created as red blood cells break down. This then flows through the small bile ducts that are located inside of the liver. Bile moves from the smaller sized ducts into the larger ones much in the same way that streams flow into a river and eventually converge into the main ducts and then exit the liver as the streams exit into a river. Part of the bile will then flow into the duodenum; the rest of the bile will flow into a storage facility and concentrate in the gallbladder. After eating, the gallbladder will then release some of the bile into the smaller sized intestine where it will then digest fats.

Any condition that causes liver inflammation or damage is liver disease. These conditions may also affect how the liver functions. Liver disease is categorized according to the cause and effect upon the liver. Causes can include things such as infection, exposure to drugs, exposure to toxic compounds, injury to the liver, autoimmune processes, genetic defects, and other conditions that may be due to deposits and build-up of metals in the liver, including iron and copper. The residual effects of such exposure are inflammation, injury, obstruction, scarring, abnormalities in blood clotting, and eventual liver failure.

Signs And Symptoms

In the beginning, liver disease may not have any signs or symptoms. Other symptoms may be quite non-specific. Weakness, lack of energy, and other symptoms may also present.

The most typical signs of acute liver disease include the following:

  • Yellowing of skin due to issues processing the bilirubin. These include jaundice, light stools, dark urine, and loss of appetite.
  • Nausea
  • Diarrhea
  • Vomiting

In addition to the conditions mentioned above, Chronic Conditions of liver disease may also include the following:

  • Itching or pruritus
  • Abdominal swelling (ascites)
  • Unexplained weight gain or loss
  • Abdominal pain

These symptoms typically present at a later stage of the disease.

General Laboratory Tests For Liver Disease

The main goal in screening for liver disease is to detect injury to the liver, evaluate the severity of the injury, and diagnose the cause. With time, these will then be monitored to watch for changes.

Early detection and screening are vital to the severity of symptoms, and many can be controlled if caught in time. The more that healthcare professionals can determine the severity, the more they can plan a care plan for managing the symptoms. The liver is fully capable of repairing injuries and in resolving inflammation if the bile ducts aren’t blocked. Blocked bile ducts can lead to cirrhosis and be permanent conditions that will lead to progressive liver damage. It’s important to monitor the status with time to help take any steps that will preserve the function of the liver.

General tests in the laboratory will measure the enzyme levels, protein, bilirubin, and other symptoms if there is an injury present.

Taking a comprehensive metabolic panel or CMP is a series of tests that are done in conjunction with general health screening. This includes several tests that will show the liver function.

A liver panel may also be ordered if there are any abnormalities in the CMP testing process results. These are done if there is any question on liver function or if there has been a liver injury.

Whenever there are abnormal test results, these tests may be administered for further evaluation of the liver. All these tests may also be administered individually to monitor a person who has been diagnosed with a liver condition. These tests may include the following:

Alanine aminotransferase or ALT. This is an enzyme that is mainly located in the liver and can also detect hepatitis.

Alkaline phosphatase or ALP. This enzyme is located in the bile ducts and liver and will increase if they are blocked.

Aspartate aminotransferase or AST. This enzyme is in the liver and other areas of the body, including the heart.

Gamma-glutamyl transferase or GGT. This enzyme is sensitive to changes in the liver status if the bile ducts are blocked.

Total bilirubin will measure the amount of bilirubin in the blood. The levels will be higher for many liver conditions.

Direct bilirubin will measure the type of bilirubin that is combined with other compounds and increases if liver disease is present.

Albumin is the main protein that is manufactured in the liver. It will tell how the liver is doing.

Total protein will measure the amount of the protein in the liver as well as the antibodies that are present to help ward off infections.

Lactate dehydrogenase or LDH. This enzyme is released with damaged tissue and may raise if there is acute liver disease.

Select Tests

Several tests may be ordered to diagnose liver dysfunction. Some are used to monitor the condition and others to diagnose.

Liver Biopsy: Small samples of the liver tissue are taken to evaluate the liver and the cells.

Ammonia: This could be elevated in the later stages of cirrhosis and liver failure.

Viral Hepatitis tests (A, B, And C): to detect viral infections in the liver.

Alpha-fetoprotein or AFP: will elevate with liver cancer.

Des-gamma-carboxy prothrombin or DCP: will also elevate with liver cancer.

Prothrombin time or PT: will show clotting function.

Iron tests: Hemochromatosis or iron metabolism disorders

Copper and Ceruloplasmin: Wilson’s Disease is a genetic copper metabolism disorder

Alpha 1 antitrypsin: will test for deficiency.

Antimitochondrial antibody or AMA: will diagnose biliary cholangitis or PBC.

There are tests for autoantibodies that will help to diagnose autoimmune hepatitis, including antinuclear antibodies or ANA. Antismooth muscle antibodies or ASMA and the F-actin antibodies for both liver and kidney microsomes or anti-LKM1. Acetaminophen levels and other overdose drug tests or if the person is doing drugs will also show.

CBC or complete blood count will show elevated white and red blood cells as well as platelets.